NL-OMON22096
招募中
不适用
DNA-testing for BRCA1/2 in breast cancer patients prior to genetic counseling: DNA-direct.
MC St Radboud / Radboud University Medical Center (Nijmegen)0 个研究点目标入组 150 人待定
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- BRCA1/2, breast cancer, borstkanker, hereditary breast cancer, erfelijke borstkanker
- 发起方
- MC St Radboud / Radboud University Medical Center (Nijmegen)
- 入组人数
- 150
- 状态
- 招募中
- 最后更新
- 去年
概览
简要总结
/A
研究者
入排标准
入选标准
- •All female breast cancer patients (recently diagnosed or in the past) referred to the department of Clinical Genetics of the Radboud University Medical Centre Nijmegen for genetic counseling.
排除标准
- •1\. Problems with (large amounts of) written Dutch text;
- •2\. Current psychological / psychiatric treatment (including medication);
结局指标
主要结局
未指定
相似试验
已完成
不适用
DNA testing for BRCA1/2 in breast cancer patients prior to genetic counseling: DNA-directBRCA gene mutationhereditary breast cancer1008362410006291NL-OMON35994niversitair Medisch Centrum Sint Radboud150
Unknown
不适用
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriersbrca1 Mutation Carrierbrca2 Mutation CarrierBreast CancerNCT00897455Gynecologic Oncology Group10,000
已完成
不适用
Testing BRCA 1/2 Mutation Using Next Generation SequencingBreast NeoplasmsBreast CancerNCT02151747Severance Hospital12
Unknown
不适用
Korean Hereditary Breast Cancer StudyBreast CancerOvarian CancerNCT00595348Korean Breast Cancer Study Group2,250
撤回
不适用
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation CarriersBRCA1 Mutation CarrierBRCA2 Mutation CarrierBreast CarcinomaNCT00899145Gynecologic Oncology Group